{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:09:50Z","timestamp":1794006590494,"version":"4.8.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To assess the Pearl Index for risk of ectopic pregnancy in women using levonorgestrel-releasing intrauterine systems (LNG-IUS) with hormonal reservoirs of 13.5 mg, 19.5 mg, or 52 mg.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS:<\/jats:title>\n            <jats:p>This was a retrospective cohort study. Women diagnosed with an ectopic pregnancy in Stockholm County, Sweden, between January 1, 2014, and December 31, 2019, were identified through the electronic medical record system. The final analysis included 2,252 cases of ectopic pregnancy. Information on age, reproductive and medical history, as well as current use of contraception was retrieved. The time of intrauterine device (IUD) insertion before ectopic pregnancy and the numbers of sold LNG-IUS during the study period were used to calculate the incidence rate for ectopic pregnancy during use per 100 woman-years (Pearl Index).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS:<\/jats:title>\n            <jats:p>Among women with an ectopic pregnancy diagnosis, 105 presented with a known type of hormonal IUD in situ, of whom 94 were included in the calculations of the Pearl Index. The estimated Pearl Index for ectopic pregnancy was 0.136 (95% CI 0.106\u20130.176) for the LNG-IUS 13.5-mg, 0.037 (95% CI 0.021\u20130.067) for the LNG-IUS 19.5-mg, and 0.009 (95% CI 0.006\u20130.014) for the LNG-IUS 52-mg. With the 52-mg LNG-IUS as referent, the relative risk (RR) for ectopic pregnancy was higher during the first year for LNG 13.5-mg (RR 20.59, 95% CI 12.04\u201335.21), and for both 13.5-mg (RR 14.49, 95% CI 9.01\u201323.3) and 19.5-mg (RR 4.44, 95% CI 1.64\u201312.00) during the total study period.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>The absolute risk of ectopic pregnancy during the use of LNG-IUS at any doses was low. The results show that the lower the dose of the IUD, the higher the risk of an ectopic pregnancy. Higher-dose LNG-IUS should be considered when providing contraceptive counseling to a woman with known risk factors for ectopic pregnancy who are considering a hormonal IUD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000004846","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T12:02:03Z","timestamp":1657281723000},"page":"227-233","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":17,"title":["The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy"],"prefix":"10.1097","volume":"140","author":[{"given":"Karin","family":"Elgemark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Graner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"McTaggart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Ramirez L\u00f6fstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"S\u00f6rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Envall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Kopp Kallner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/GRF.0b013e31802f4f79","article-title":"Ectopic pregnancy","volume":"50","author":"Walker","year":"2007","journal-title":"Clin Obstet Gynecol"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/GRF.0b013e3182516d7b","article-title":"Ectopic pregnancy: history, incidence, epidemiology, and risk factors","volume":"55","author":"Marion","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(05)67103-6","article-title":"Ectopic pregnancy","volume":"366","author":"Farquhar","year":"2005","journal-title":"Lancet"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1056\/NEJMcp0810384","article-title":"Clinical practice. Ectopic pregnancy","volume":"361","author":"Barnhart","year":"2009","journal-title":"N Engl J Med"},{"key":"R5-20250423","first-page":"e251","article-title":"Long-acting reversible contraception: implants and intrauterine devices. Practice Bulletin No. 186. American College of Obstetricians and Gynecologists","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00404-013-2929-2","article-title":"Ectopic pregnancy: a review","volume":"288","author":"Rana","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2147\/IJWH.S99705","article-title":"Levonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counseling","volume":"8","author":"Costescu","year":"2016","journal-title":"Int J Womens Health"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000019","article-title":"Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial","volume":"122","author":"Nelson","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.fertnstert.2011.12.003","article-title":"A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena","volume":"97","author":"Gemzell-Danielsson","year":"2012","journal-title":"Fertil Steril"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/13625187.2016.1212987","article-title":"A multicentre, open-label, randomised phase III study comparing a new levonorgestrel intrauterine contraceptive system (LNG-IUS 8) with combined oral contraception in young women of reproductive age","volume":"21","author":"Borgatta","year":"2016","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.contraception.2016.11.005","article-title":"A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population","volume":"95","author":"Fan","year":"2017","journal-title":"Contraception"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.fertnstert.2016.02.036","article-title":"A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant","volume":"106","author":"Apter","year":"2016","journal-title":"Fertil Steril"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.contraception.2016.02.004","article-title":"A phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents","volume":"93","author":"Gemzell-Danielsson","year":"2016","journal-title":"Contraception"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejogrb.2016.11.022","article-title":"Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use","volume":"210","author":"Gemzell-Danielsson","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/aogs.13564","article-title":"Levonorgestrel intrauterine contraceptive systems (13.5 mg and 52 mg) and risk of ectopic pregnancy","volume":"98","author":"Graner","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R18-20250423","first-page":"558","article-title":"A guide to interpreting contraceptive efficacy studies","volume":"76","author":"Trussell","year":"1990","journal-title":"Obstet Gynecol"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/ejc.8.2.87.92","article-title":"Recommendation for confidence interval and sample size calculation for the Pearl Index","volume":"8","author":"Gerlinger","year":"2003","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.contraception.2015.01.011","article-title":"Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices: the European Active Surveillance Study for Intrauterine Devices","volume":"91","author":"Heinemann","year":"2015","journal-title":"Contraception"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1097\/AOG.0000000000004726","article-title":"Method of hormonal contraception and protective effects against ectopic pregnancy","volume":"139","author":"Kopp-Kallner","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12884-015-0613-1","article-title":"Risk factors for ectopic pregnancy: a multi-center case-control study","volume":"15","author":"Li","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.fertnstert.2014.03.004","article-title":"Pharmacokinetics of two low-dose levonorgestrel-releasing intrauterine systems and effects on ovulation rate and cervical function: pooled analyses of phase II and III studies","volume":"101","author":"Apter","year":"2014","journal-title":"Fertil Steril"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2019.03.044","article-title":"Comparing bleeding patterns for the levonorgestrel 52 mg, 19.5 mg, and 13.5 mg intrauterine systems","volume":"100","author":"Goldthwaite","year":"2019","journal-title":"Contraception (Stoneham)"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/13625187.2014.894184","article-title":"Impact of a new levonorgestrel intrauterine system, Levosert(\u00ae), on heavy menstrual bleeding: results of a one-year randomised controlled trial","volume":"19","author":"Mawet","year":"2014","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1080\/13625187.2018.1539164","article-title":"Intrauterine device continuation rates and reasons for discontinuation in a Central European clinic with a high standard of care and ultrasound follow-up: a retrospective cohort study","volume":"23","author":"Bachofner","journal-title":"Eur J Contracept Reprod Health Care"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:03:20Z","timestamp":1745431400000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004846","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"assertion":[{"value":"2022-02-14","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}